As AKT or MAPK signaling pathways are often involved in cancer cell survival, we examined the activation of AKT and ERK proteins and found that LGR5 overexpression resulted in the downregulation of AKT and ERK phosphorylation as well as AKT and ERK protein levels (Fig. 7C). The gene discussed is AKT1; the disease is cancer.